Healthcare provider profile · identity verified

Harvey Hakim, M.D.

Internal Medicine · EASTON, PA · NPI 1740282169

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	714	195
Amlodipine Besylate	Amlodipine Besylate	544	144
Rosuvastatin Calcium	Rosuvastatin Calcium	404	121
Levothyroxine Sodium	Levothyroxine Sodium	395	108
Metoprolol Succinate	Metoprolol Succinate	249	68
Losartan Potassium	Losartan Potassium	242	70
Metformin Hcl Er	Metformin Hcl	195	52
Pantoprazole Sodium	Pantoprazole Sodium	185	57
Lisinopril	Lisinopril	175	44
Simvastatin	Simvastatin	175	48
Metformin Hcl	Metformin Hcl	166	45
Omeprazole	Omeprazole	139	46
Eliquis	Apixaban	129	27
Hydrochlorothiazide	Hydrochlorothiazide	122	36
Gabapentin	Gabapentin	118	35
Sertraline Hcl	Sertraline Hcl	116	30
Lorazepam	Lorazepam	115	25
Ezetimibe	Ezetimibe	112	29
Escitalopram Oxalate	Escitalopram Oxalate	111	30
Alendronate Sodium	Alendronate Sodium	110	28
Valsartan	Valsartan	105	37
Allopurinol	Allopurinol	104	29
Fluticasone Propionate	Fluticasone Propionate	99	42
Tamsulosin Hcl	Tamsulosin Hcl	97	28
Duloxetine Hcl	Duloxetine Hcl	96	28
Jardiance	Empagliflozin	95	23
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	94	25
Metoprolol Tartrate	Metoprolol Tartrate	91	24
Ozempic	Semaglutide	86	18
Zolpidem Tartrate	Zolpidem Tartrate	85	19
Pravastatin Sodium	Pravastatin Sodium	81	21
Tramadol Hcl	Tramadol Hcl	79	20
Furosemide	Furosemide	70	19
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	69	19
Warfarin Sodium	Warfarin Sodium	69	suppressed
Alprazolam	Alprazolam	67	17
Benazepril Hcl	Benazepril Hcl	66	16
Xarelto	Rivaroxaban	65	15
Glimepiride	Glimepiride	64	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	64	14
Albuterol Sulfate Hfa	Albuterol Sulfate	61	26
Potassium Chloride	Potassium Chloride	61	15
Trazodone Hcl	Trazodone Hcl	57	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	52	15
Carvedilol	Carvedilol	51	15
Irbesartan	Irbesartan	50	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	16
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	49	12
Ramipril	Ramipril	48	13
Spironolactone	Spironolactone	48	13
Finasteride	Finasteride	47	11
Citalopram Hbr	Citalopram Hydrobromide	45	13
Montelukast Sodium	Montelukast Sodium	45	15
Trulicity	Dulaglutide	45	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	44	13
Famotidine	Famotidine	43	15
Torsemide	Torsemide	39	12
Synthroid	Levothyroxine Sodium	37	11
Clonazepam	Clonazepam	35	suppressed
Azelastine Hcl	Azelastine Hcl	34	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	34	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	11
Prednisone	Prednisone	32	21
Topiramate	Topiramate	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Meloxicam	Meloxicam	30	15
Mirtazapine	Mirtazapine	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	11
Buspirone Hcl	Buspirone Hcl	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Telmisartan	Telmisartan	25	suppressed
Cephalexin	Cephalexin	24	21
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Atenolol	Atenolol	23	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	23	suppressed
Methocarbamol	Methocarbamol	23	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	23	suppressed
Clopidogrel	Clopidogrel Bisulfate	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	18
Mounjaro	Tirzepatide	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Rizatriptan	Rizatriptan Benzoate	22	suppressed
Bumetanide	Bumetanide	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	15
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Indapamide	Indapamide	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	19	suppressed
Xultophy 100-3.6	Insulin Degludec/Liraglutide	19	suppressed
Carbamazepine Er	Carbamazepine	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	15
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	17	suppressed
Methylprednisolone	Methylprednisolone	16	16
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Pregabalin	Pregabalin	16	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Nystatin	Nystatin	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Amiloride Hcl	Amiloride Hcl	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	11	suppressed
Diazepam	Diazepam	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error